The drugmaker is debuting a DTC campaign for the older constipation drug, despite a crowded therapeutic category and potential generics on the horizon.
The reveal comes days before hydrocodone products jump to a more restrictive access tier.
The FDA's Office of Prescription Drug Promotion says Pacira's promotional materials for Exparel are "extremely concerning," but the drugmaker tells investors the fuss is probably because opioids have been getting a lot of attention lately.
Satisfaction levels among pharma-based respondents fell, but didn't exactly tank
Any time a firm needs to save money, high-salaried executives are targets
A level of trust happens when you have an in-person relationship that just can't be recreated online